Department of Immunology, Genetics and Pathology

For staff

The department’s information for staff is available in the staff gateway

For students

The department’s information for students is available in the student gateway

Research infrastructures

Seven research infrastructures in the form of service facilities are affiliated with the department

Rudbeck seminars

Here you can find the programme for the Rudbeck seminars

New research findings from IGP

  • New biomarkers for detecting cancer

    Biomarkers in the blood could be used for the early detection of colorectal cancer, lung cancer and ovarian cancer. A new study from IGP shows that the performance of such biomarkers is comparable to or better than established tests and could be developed for clinical use. Läs mer

  • Different paediatric brain tumours originate from the same type of cell

    Researchers at IGP have discovered that severe brain tumours in children that appear to be completely different actually arise from the same type of cell. This cell type can give rise to tumours in the pineal gland, the retina and the cerebellum. The discovery that these tumours are related may make it possible to treat them in similar ways. Läs mer

  • Immunostimulatory gene therapy has been evaluated for patients with malignant melanoma

    A new clinical study shows promising results from treatment with immunostimulatory gene therapy in combination with checkpoint inhibitors for patients with malignant melanoma. The study has been published in the scientific journal Nature Communications. Läs mer

  • IGP research “Best Basic Investigation” in Journal of Nuclear Medicine

    A research team at IGP has had their latest study selected as Best Basic Investigation and overall Featured Article of the Month in the highly ranked Journal of Nuclear Medicine. The work demonstrates a strong therapeutic potential of a new targeted radiopharmaceutical for cancer treatment. Läs mer

  • Genetic changes associated with relapse of mantle cell lymphoma

    A new study from IGP shows how mantle cell lymphoma changes over time and that new genetic risks arise in cases of relapse. In addition, the genetic changes are affected by the treatment the patient has received. The results show that it is important to perform genetic analyses in cases of relapse and to consider treatments that have less impact on genetic risk. Läs mer

Show more

Last modified:

FOLLOW UPPSALA UNIVERSITY ON

Uppsala University on Facebook
Uppsala University on Instagram
Uppsala University on Youtube
Uppsala University on Linkedin